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ABSTRACT: The N-terminal domain of cardiac troponin I (cTnI) comprising residues 33-80 and lacking
the cardiac-specific amino terminus forms a stable binary complex with the C-terminal domain of cardiac
troponin C (cTnC) comprising residues 81-161. We have utilized heteronuclear multidimensional NMR
to assign the backbone and side-chain resonances of Ca2+-saturated cTnC(81-161) both free and bound
to cTnI(33-80). No significant differences were observed between secondary structural elements determined
for free and cTnI(33-80)-bound cTnC(81-161). We have determined solution structures of Ca2+-saturated
cTnC(81-161) free and bound to cTnI(33-80). While the tertiary structure of cTnC(81-161) is
qualitatively similar to that observed free in solution, the binding of cTnI(33-80) results mainly in an
opening of the structure and movement of the loop region between helices F and G. Together, these
movements provide the binding site for the N-terminal domain of cTnI. The putative binding site for
cTnI(33-80) was determined by mapping amide proton and nitrogen chemical shift changes, induced by
the binding of cTnI(33-80), onto the C-terminal cTnC structure. The binding interface for cTnI(33-80),
as suggested from chemical shift changes, involves predominantly hydrophobic interactions located in
the expanded hydrophobic pocket. The largest chemical shift changes were observed in the loop region
connecting helices F and G. Inspection of available TnC sequences reveals that these residues are highly
conserved, suggesting a common binding motif for the Ca2+/Mg2+-dependent interaction site in the TnC/
TnI complex.
The binding of Ca2+ to the troponin complex, located on
the thin filament, triggers muscle contraction via Ca2+-
induced conformational changes within the complex. Tropo-
nin consists of TnC,1 the Ca2+ binding subunit, which
interacts with both TnI, the inhibitory subunit, and TnT, the
tropomyosin binding subunit, on the actin-tropomyosin thin
filament. Upon Ca2+ binding to the regulatory domain of
TnC, protein-protein interactions within the complex are
modified, facilitating the release of the inhibitory TnI domain
from actin and triggering muscle contraction.
The cardiac isoforms of TnC and TnI both differ signifi-
cantly from the skeletal forms. In the cardiac isoform of TnC,
site I is naturally inactive (1). Calcium binding to the
N-terminal regulatory domain of cTnC has been suggested
to result in a “closed” conformation in contrast to Ca2+
activation of sTnC which results in a larger conformational
change leading to an “open” form with an exposed hydro-
phobic pocket (2). The cardiac isoform of TnI is unique in
that it contains an additional N-terminal extension of
approximately 32 residues. This extension has two adjacent
serine residues that can be phosphorylated by PKA. Phos-
phorylation has been demonstrated to modulate cardiac
function by reducing the Ca2+ affinity for the N-terminal
regulatory site of cTnC (3). Cardiac TnC and TnI are known
to interact in an antiparallel manner such that the C-terminal
domain of TnC interacts with the N-terminal domain of TnI
(4). An N-terminal fragment of cTnI, corresponding to
residues 33-80 and lacking the cardiac-specific N-terminus,
was found to be sufficient for interaction with the C-terminal
domain of cTnC in a manner identical to that observed for
cTnI(33-211), a full-length recombinant cTnI lacking the
cardiac-specific amino terminus (4). Cardiac TnI(33-80) is
homologous with the first 47 residues of sTnI.
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As a prerequisite to studying the intact cardiac TnIC
complex, structural studies on the C-terminal domain of cTnC
both free and bound to cTnI(33-80) were initiated. Shortly
after we had completed the resonance assignment and
elucidation of the secondary structure of cTnC(81-161) both
free and bound to cTnI(33-80), a figure comparing the
tertiary folds of the C-terminal domains of free skeletal and
cardiac TnC became available (5). Structures of the free
cardiac and skeletal C-terminal domains were found to be
similar, as predicted. Although solution and crystal structures
of isolated TnC domains are available, little structural
information is available on the TnIC interaction. Recently,
a cocrystal structure of skeletal TnC complexed with the
N-terminal 47 residues of skeletal TnI has been reported (6).
A 31 residue R-helical region of sTnI was shown to make
both polar and van der Waals interactions with the C-terminal
domain of sTnC. The overall conformation of the C-terminal
domain of sTnC bound to sTnI(1-47) was found to be
similar to that of the free protein (6). The major difference
in the complex was an unwinding of the D/E to an extended
linker. This permitted the N- and C-terminal domains of
sTnC to come into close proximity, forming a narrow
interdomain cleft in the sTnC/sTnI(1-47) complex (6).
We have determined the solution structure of cTnC(81-
161) both free and bound to cTnI(33-80). Structure com-
parison indicates that the free and bound structures are
qualitatively similar, but do show some specific differences,
mainly an opening of the structure and movement of the loop
region between helices F and G in the bound form. Backbone
amide resonances which undergo significant chemical shift
changes upon complex formation have been identified and
used to map the binding site for cTnI(33-80). Based on
perturbation of residues undergoing large chemical shifts,
the N-terminal domain of cTnI binds primarily to helix F,
the short loop connecting helices F and G, and the end of
helix H. These regions of cTnC constitute a major portion
of the C-terminal hydrophobic pocket.
MATERIALS AND METHODS
Labeled Recombinant Proteins. Recombinant cTnC(81-
161) was cloned into pET23d+ and overexpressed in BL21-
(DE3) cells. Uniformly 15N- and 13C-enriched cTnC(81-
161) was obtained by growing BL21(DE3) cells with the
appropriate plasmid in defined media (7). Routinely, 2 L of
cells was grown at 37 °C until an absorbance at 600 nm of
0.6 was reached. Cultures were induced with 1 mM IPTG
and grown overnight. Cells were collected by centrifugation,
and lysed by treatment with lysozyme/sucrose followed by
brief sonication. The cell suspension was centrifuged and
the supernatant applied to a Pharmacia Q-Sepharose column
equilibrated in buffer A (50 mM Tris, pH 7.5, and 6.2 mM
EDTA). Cardiac TnC(81-161) was eluted using a 0-1 M
KCl linear gradient. Fractions containing cTnC(81-161)
were pooled, concentrated, and applied to a Pharmacia
Superdex 75 column equilibrated in buffer A containing 150
mM NaCl. Fractions containing cTnC(81-161) were pooled,
concentrated, and judged to be homogeneous by SDS-
polyacrylamide gel electrophoresis and staining with Coo-
massie Brilliant Blue.
Recombinant cTnI(33-80) was cloned into pET3d+ and
overexpressed in BL21(DE3) in LB media. Cells were
induced for 3 h with IPTG and harvested as described above.
Since cTnI(33-80) is produced as inclusion bodies, cells
were initially suspended in urea-containing buffer (8 M urea,
500 mM Tris/HCl, pH 8.0, 500 mM NaCl, 1 mM EDTA,
30 mM â-mercaptoethanol, and 1 mM PMSF). The cell
suspension was sonicated and centrifuged, and the pellet was
discarded. The supernatant was dialyzed overnight against
buffer B (6 M urea, 25 mM Tris/HCl, pH 8.0, 1 mM EDTA,
1 mM PMSF, and 1 mM DDT). The dialysate was centri-
fuged, and loaded onto a CM-Sepharose column equilibrated
in buffer B. Cardiac cTnI(33-80) eluted at 25-40% using
a 0-750 mM linear gradient. The sample was dialyzed
against 300 mM NaCl, 10 mM Tris, pH 8.0, 1 mM DTT,
and 1 mM PMSF. After dialysis, the sample was lyophilized,
dissolved in buffer B, and loaded onto a Superdex 75 column
equilibrated in buffer B containing 150 mM NaCl. Cardiac
cTnI(33-80) eluted as a symmetrical peak and was judged
to be homogeneous by SDS-polyacrylamide electrophoresis
and staining with Coomassie Brillant Blue.
Calcium-saturated [15N,13C]cTnC(81-161)/cTnI(33-80)
complex was formed by slowly adding cTnI(33-80) in
buffer B into a solution of cTnC(81-161) and washing out
the urea as previously described (4). In the absence of urea,
any free cTnI(33-80) that does not bind to cTnC(81-161)
precipitated from solution and was removed by centrifuga-
tion. The complex was also prepared by a slightly modified
method of Jha et al. (8). No significant differences in the
1H-15N HSQC spectra of cTnC(81-161) were observed for
either method of complex formation.
Light Scattering Experiments. Dynamic light scattering
experiments were conducted on cTnC(81-161) and cTnC-
(81-161)/cTnI(33-80), under the conditions of the NMR
experiments as described below, using a Protein Solutions
instrument. Sixteen independent measurements were per-
formed for both samples. In both cases, results indicated
>95% monodisperse solutions with diffusion coefficients
appropriate for the known molecular weights for free cTnC-
(81-161) and the complex.
NMR Methods. NMR experiments were collected at 40
°C for both the free protein and the complex. Two separate
1 mM samples of the free protein, [15N,13C]cTnC(81-161)
or [15N]cTnC(81-161), were prepared in NMR buffer
containing 20 mM Tris-d11, pH 6.8, 100 mM KCl, 20 mM
DTT, 15 mM CaCl2, 0.1 mM leupeptin, and 0.1 mM
pefabloc, 10% D2O. Two separate complex samples of
0.7-1 mM [15N,13C]cTnC(81-161)/cTnI(33-80) or [15N]-
cTnC(81-161)/cTnI(33-80) in the above NMR buffer were
also prepared. 1H, 13C, and 15N chemical shift referencing
have been obtained following the guidelines proposed by
Wishart et al. (9). The idea is to use indirect referencing for
the multidimensional heteronuclear NMR experiment. The
1H chemical shift standard was obtained from DSS in water
(1 mM, pH 7.0, 40 °C). Both the 13C and 15N chemical shifts
were referenced to the frequency ratio: 13C/1H ) 0.25144953
and 15N/1H ) 0.101329118, respectively. NMR experiments
were performed on Varian 600 and 800 MHz Inova
spectrometers equipped with pulse-field gradient units and
a pfg triple resonance probe. Sequential assignments were
obtained from sensitivity-enhanced gradient HSQC (10), 15N-
edited NOESY-HSQC with 70 and 150 ms mixing times and
15N-edited TOCSY-HSQC (11), CN-NOESY-HSQC with a
150 ms mixing time (12), HNCRCâ (13), (Hâ)CâCR(CO)NNH
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(14), and HNCO (15) experiments. Spectra recorded for side-
chain assignments include H(CCO)NH and C(CO)NH (16-
18) for the aliphatic resonances and (Hâ)Câ(CçCä)Hä and
(Hâ)Câ(CçCäC)H (19) for aromatic resonances. The three-
bond coupling constant 3JHN-HR was obtained from the
HNHA experiment (20, 21). Coupling constants were
calculated from the ratio of the intensity of the cross-peak
(Ix) and the diagonal peak (Id) according to
These coupling constants were related to the æ dihedral angle
using the relationship described by Vuister and Bax (20). A
total of 13 ł1 torsion angles were calculated using An-
gleSearch software (22) for cTnC(81-161) bound to cTnI-
(33-80). The ratios of cross-peak intensities for â-protons
obtained from an HNHB (23, 24) experiment as well as
3JHN-HR values and HN to Hâ, HN to HR, HNi+1 to HR, and
HN to HNi+1 NOEs were used as input for conformational
grid search in dihedral-angle space using 6° steps to explore
possible side-chain geometries in cTnC(81-161) bound to
cTnI(33-80). Pulse sequences together with the experimental
parameters used in resonance assignment of both free and
bound cTnC(81-161) are listed in Table 1. Data were
processed with either FELIX 97.2 (BioSym) or nmrPipe (25)
and analyzed with the program FELIX 97.2.
Tertiary Structure Calculation. Three-dimensional struc-
tures based on interproton distance restraints were generated
using the hybrid distance geometry-simulated annealing
approach (26-29) and the X-PLOR program (30). The
topology and parameter files in X-PLOR were modified to
incorporate specific characteristics for the Ca2+ ion. Values
for distances between the calcium ion and the calcium
binding ligands were taken from Strynadka and James (31).
Interproton distances were derived from cross-peak intensities
in the 70, 150 ms 15N-edited NOESY-HSQC and 150 ms
CN-NOESY-HSQC. Peak intensities from the NOE cross-
peaks were classified as strong (1.8-2.8 Å), medium (1.8-
3.7 Å), weak (1.8-5.2 Å), and very weak (1.8-6.0 Å) for
HN to HN NOEs and were classified as strong (1.8-3.6 Å),
medium (1.8-4.6 Å), weak (1.8-5.8 Å), and very weak
(1.8-7.0 Å) for all others. Pseudoatom corrections were
added to NOEs involving the methyl groups. To NOEs
involving nonstereospecifically assigned methylene protons
(32, 33), center averaging was employed. Two distance
restraints were used for each hydrogen bond: one between
the hydrogen and the acceptor atom of 1.8-2.0 Å and the
other between the donor heavy atom and the acceptor atom
of 2.7-3.0 Å. A set of 500 substructures was generated using
the metric matrix distance geometry program (34) followed
by the distance geometry-simulated annealing protocol as
described in the X-PLOR manual (30). Torsion angle
constraints were initialized to 5 kcal mol-1 rad-2; then at
the beginning of the annealing they were increased to 200
kcal mol-1 rad-2. The initial annealing temperature was 2000
K, and 50 K decrements allowed the system to cool to a
final temperature of 100 K. Force constants for the NOE-
derived distance restraints were maintained at 50 kcal/(molâ
Å2) through the whole refinement process, whereas the
repulsive force constant was increased from 0.003 kcal/(molâ
Å2) to 4 kcal/(molâÅ2). After refinement, 20 accepted
structures for each, having no violations of the input NOE
restraints greater than 0.2 Å, were analyzed. The Procheck-
NMR program (35, 36) was used to check the structure
quality.
Determination of Relaxation Parameters for cTnC(81-
161) Bound to cTnI(33-80). 15N T2 and {1H}-15N NOE
spectra were acquired at 600 MHz. Pulse sequences used to
record 15N NMR relaxation parameters are essentially those
previously described (37). 15N T2 values were determined
in a series of inversion-recovery experiments with delays
(T) of 0, 32, 64, 96, 128, 160, 192, and 224 ms. Estimation
of noise level was obtained with duplicate spectra at T ) 0,
64, and 160 ms. Heteronuclear NOE values were obtained
from eq 2 using peak intensities in the {1H}-15N NOE
spectra:
where Isat is the cross-peak intensity in the presence of proton
saturation and Iunsat is the cross-peak intensity in the absence
of proton saturation. Spectra were recorded in the presence
and absence of a proton presaturation period of 3s.
RESULTS
Complex Formation and Resonance Assignments. To study
the interaction of recombinant cTnC(81-161) with recom-
binant cTnI(33-80), a 1:1 complex was formed between the
two proteins by slowly adding aliquots of cTnI(33-80) in 6
M urea to a concentrated solution of cTnC(81-161). Urea
was removed by repeated washing with NMR buffer. This
procedure was repeated until a 1:1 complex was formed as
previously described (4). Under conditions of complex
formation, excess free cTnI(33-80) was insoluble and could
be removed by centrifugation. Complex formation was
monitored by SDS-polyacrylamide and native acrylamide
gel electrophoresis (Figure 1). Native acrylamide gel elec-
trophoresis demonstrated that cTnC(81-161)/cTnI(33-80)
formed a tight 1:1 complex (Figure 1A). SDS-polyacryla-
Ix/Id ) tan
2 [2ð(3JHN-HR)] (1)
FIGURE 1: Complex formation between cTnC(81-161) and cTnI-
(33-80). (A) Native 15% acrylamide gel electrophoresis of cTnC-
(81-161) and cTnI(33-80) used to visualize the cTnC(81-161)â
cTnI(33-80) complex before NMR structural studies. Lane 1,
cTnC(81-161)/cTnI(33-80) complex; lane 2, cTnC(81-161). (B)
15% SDS-polyacrylamide gel electrophoresis of cTnC(81-161),
cTnI(33-80), cTnC(81-161)âcTnI(33-80) complex, and aprotinin.
Lane 1, molecular mass standards (97 kDa, phosphorylase; 66.2
kDa, bovine serum albumin; 26.6 kDa, triosephosphate isomerase;
21.5 kDa, trypsin inhibitor; 14.4 kDa, lysozyme); lane 2, cTnC-
(81-161); lane 3, cTnC(81-161)âcTnI(33-80) complex; lane 4,
cTnI(33-80); lane 5, aprotinin (6.5 kDa).
NOE ) Isat/Iunsat - 1 (2)
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mide gel electrophoresis was used to visualize the purity of
the final complex (Figure 1B). The unusual mobility of
cTnC(81-161) in the denaturing system is most likely due
to residual Ca2+ binding at sites III and IV resulting in
incomplete denaturation. Gel filtration using a Pharmacia
Superdex 75 column yielded a single symmetrical peak at
an elution volume consistent with the molecular mass of the
complex (15.2 kDa). In addition, dynamic light scattering
intensities of cTnC(81-161), and cTnC(81-161)/cTnI(33-
80), under conditions of the NMR experiment, indicated that
>95% of the free protein and the complex were monodis-
perse. The possibility of nonspecific hydrophobic interac-
tions, particularly in free cTnC(81-161), was investigated
by titration of a 1 mM sample with TFE and monitoring the
dynamic light scattering intensities. The addition of up to
15% TFE did not decrease or alter the size of the particle
distribution. Relaxation studies, presented below, also support
the absence of aggregation of cTnC(81-161) under condi-
tions of the NMR experiments.
Figure 2 compares the 1H-15N HSQC spectra of 15N-
labeled cTnC(81-161) and the 15N-labeled cTnC(81-161)/
cTnI(33-80) complex. Comparison of the spectra indicates
chemical exchange between the bound and free cTnC(81-
161) is slow on the NMR time scale. Titration of cTnI(33-
80) into a solution of cTnC(81-161) was not feasible since
cTnI(33-80) is insoluble in the absence of urea or cTnC.
Of the 81 non-proline residues in cTnC(81-161), 78 and
75 1H-15N correlations were observable in the free and
bound forms, respectively. Assignments were made through
analysis of experiments listed in Table 1. Backbone assign-
ments were initiated from known residue assignments
corresponding to Gly110, Gly146, Ile112, and Ile148 (4).
In several cases, 1H-15N correlations could be assigned to
specific residue types based on selective 15N-labeling experi-
ments in full-length cTnC (4). In general, sequential back-
bone assignments were made using (Hâ)CâCR(CO)NNH and
the NHCRCâ spectra. Three-dimensional NOESY-HSQC
spectra were used to confirm residue assignments by
identifying sequential dNN(i, i+1), dNN(i, i+3), and dRN(i, i+1)
NOEs.
Identification of Secondary Structure. Secondary structures
for cTnC(81-161) both free and in a complex with cTnI-
(33-80) were determined from analysis of NOE patterns,
3JHNHR coupling constants, magnitude of the dNR/dRN NOE
ratios (38), and the chemical shift index (CSI). The CSI was
compiled utilizing CR, C′, Câ, and HR chemical shift values
for cTnC(81-161) free and bound to cTnI(33-80) (39-
41). NOESY-HSQC spectra obtained with 70 and 150 ms
mixing times and the CN-NOESY-HSQC spectrum recorded
with a 150 ms mixing time were used to analyze NOE
connectivities. A HNHA experiment was used to derive
3JHNHR coupling constants. Values of 3JHNHR greater than 8
Hz or smaller than 5 Hz were taken to indicate â-strand and
R-helix, respectively. Figure 3 presents a summary of the
sequential and medium-range NOE, CSI, and 3JHNHR coupling
constant information used to determine the secondary
structure of free and cTnI(33-80)-bound cTnC(81-161). In
free cTnC(81-161), four regions of helical structure were
found corresponding to residues 93-103, 114-123, 130-
139, and 150-158 (Figure 3A; Table 2). Two short â-strands
were found between residues 111-113 and 147-149 (Figure
3A). The determined secondary structure is also consistent
with that previously reported for the C-terminal domain of
cTnC (5). In the free C-terminal domain, conformational
exchange was observed for a number of residues in helices
F and H. Figure 3B summarizes the sequential and medium-
range NOEs, 3JHNHR coupling constants, and CSI observed
for cTnC(81-161) bound to cTnI(33-80). No secondary
structural differences were observed in the bound protein
(Figure 3, Table 2). Amide proton resonances for both Ile112
and -148 are shifted downfield, as observed in wild-type
cTnC (4, 5), as a consequence of interstrand hydrogen
bonding within the short â-sheet between calcium binding
sites III and IV. The presence of these downfield-shifted
amides can be used to monitor â-sheet formation upon Ca2+
binding to sites III and IV (42, 43). Cross-strand NOEs have
also been found between HR-HR and HR-NH residues
involved in the short â-sheet as was previously reported (42).
Downfield chemical shifts are also observed for the amide
protons of Gly110 and Gly146, as a consequence of hydrogen
bonding with the carboxylate of Asp at position 1 in Ca2+
binding loops III and IV, respectively. The amide proton of
Gly146 is shifted 0.05 ppm more upfield in the complex than
in free cTnC (Figure 2). This may reflect a weaker interaction
between the amide of Gly146 and the side chain of Asp141
in the complex. The slight upfield shift of Gly146 in the
complex can also be used to monitor complex formation and
to ensure a 1:1 stoichiometry. In addition, the amide proton
FIGURE 2: Two-dimensional 1H-15N HSQC spectra of 15N-labeled
cTnC(81-161) free (A) and bound to cTnI(33-80) (B) recorded
at 600 MHz. Several of the correlations are labeled corresponding
to residue number.
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of Thr129 is shifted downfield (Figure 2B) in cTnC(81-
161) upon binding cTnI(33-80). The downfield shift in the
amide proton of Thr129 suggests formation of a tight
hydrogen bond in the complex. This tight hydrogen bond is
the result of Thr129 acting as an N-cap residue. As
mentioned by Dasgupta and Bell (44), a specific pair of
hydrogen bonds is often observed between the N-cap side
chain (often Thr) and the amide hydrogen of the residue at
N+3. The ç-hydroxyl group of Thr129 forms a hydrogen
bond with the backbone amide of Asp132, and the side chain
in turn forms a hydrogen bond with the amide of Thr129.
Thr129 also exhibits the characteristic ,ª values for the
N-cap residue (45). In the bound structure, backbone torsional
angles for  (-87.3°) and ª (+175.0°) were found to be in
the range expected for N-cap residues. This is not observed
in the free protein. The value of the 3JNH-HR coupling constant
for Thr129 in the bound form was 9 Hz while in the free
protein the 3JNH-HR coupling constant for Thr129 was found
Table 1: Varian Inova 600 MHz Acquisition Parameters for NMR Experiments
nucleus data points spectral width (Hz)
experiment t1 t2 t3 t1 t2 t3 t1 t2 t3 nt
15N-1H HSQC 15N 1H 64 2048 2000 8000 8
15N-edited 1H 15N 1H 64 32 1024 8000 2000 8000 28
NOESY-HSQC
15N-edited 15N 1H 1H 32 128 1028 2000 8000 8000 16
TOCSY-HSQC
HNCO 13CO 15N 1H 64 32 1024 3500 1700 8000 32
HNCRCâ 13CR,â 15N 1H 40 32 1024 9000 2000 8000 48
(Hâ)CâCR 13CR,â 15N 1H 46 32 1024 9000 2000 8000 40
(CO)NNH
H(CCO)NH 13C 15N 1H 64 32 1152 3600 2000 9000 16
C(CO)NH 13C 15N 1H 64 32 1152 9178 2000 9000 16
(Hâ)Câ(CçCä)Hä 13C 1H 32 1152 4800 9000 64
(Hâ)Câ (CçCäC)H 13C 1H 32 1152 4500 9000 64
CN-NOESY- 1H 13C 1H 100 32 960 6000 5000 9000 16
HSQC 15N
HNHR 1HR 15N 1H 64 32 1024 6000 2000 8000 40
HNHâ 1Hâ 15N 1H 64 32 1024 6600 2000 6600 64
FIGURE 3: Summary of short- and medium-range NOE connectivites for NH and CRH protons, 3JHNHR coupling constants, and consensus
chemical shift index (CSI) for free (A) and cTnI(33-80)-bound (B) cTnC(81-161). Helices and â-strands determined form the data are
shown aligned with the amino acid sequence.
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to be only 4.6 Hz. Also, a 2 ppm upfield shift in the 13CR
resonance and a 2.6 ppm downfield shift in the 13Câ
resonance were observed for Thr129 of cTnC(81-161) when
bound to cTnI(33-80). These chemical shift changes have
been suggested to result from the unusually large value of
ª for the N-cap residue (46). In the free protein, the amide
hydrogen of Thr129 is too far away, 4.9 Å, from the side
chain of Asp132 to form a hydrogen bond as compared to
the complex where this distance is only 2.8 Å. In the skeletal
complex, Thr127, homologous to Thr129 in cardiac, can form
an intramolecular hydrogen bond with Glu130 (6).
Side-Chain Assignment of cTnC(81-161) Free and Bound
to cTnI(33-80). Backbone assignments of the HN, 15N, 13CR,
13Câ, and HR resonances obtained from heteronuclear triple
resonance three-dimensional experiments on [15N,13C]cTnC-
(81-161) in both the free and bound forms were used as
starting points for side-chain assignments. Side-chain signals
were assigned from a series of 3D experiments including
TOCSY-HSQC, H(CCO)NH, C(CO)NH, CN-NOESY-
HSQC, and NOESY-HSQC experiments (Table 1). Using
this combination of experiments, extensive cross-checks
could be made to avoid assignment errors. Resonances of
most aliphatic and aromatic residues were unambiguously
assigned in free cTnC(81-161). The aromatic rings of Tyr
and Phe were assigned using a combination of (Hâ)Câ(CçCä)-
Hä and (Hâ)Câ(CçCäC)H, CN-NOESY-HSQC, as well as
previous assignments on selectively Phe-labeled cTnC and
DQF-COSY experiments of full-length cTnC (4). Aromatic
spin systems previously delineated were sequentially assigned
based on characteristic NOEs from the aromatic protons to
the NH, CRH, and CâH protons and NOEs with neighboring
residues. Aliphatic side chains of Leu, Ile, and Val were
assigned using a combination of CN-NOESY-HSQC, TOCSY-
HSQC, and NOESY-HSQC experiments. These experiments
yielded significantly higher sensitivity in the free C-terminal
domain of cTnC than in the higher molecular weight
complex. Several side-chain NH2 resonances of Lys, Asn,
and Gln were also assigned from the CN-NOESY-HSQC
and NOESY-HSQC experiments. The inability to completely
assign aliphatic side chains, particularly in the bound form,
was the result of line broadening due to conformational
exchange in the C-terminal domain of cTnC, particularly for
residues at the end of helix F and in the H helix. Spectral
overlap precluded the sequence-specific assignment of
several aliphatic side chains and characterization of their
interresidue NOEs in both the free protein and the complex.
Interestingly, in the cTnC(81-161)/cTnI(33-80) complex,
the hydroxyl proton of Thr124 could be assigned as a broad
resonance at 5.45 ppm in the CN-NOESY-HSQC spectrum.
Free and cTnI(33-80)-Bound Structures of cTnC(81-
161). Structures of the Ca2+-loaded forms of free and cTnI-
(33-80)-bound cTnC(81-161) were generated using the
hybrid distance geometry-simulated annealing protocol. A
final set of 20 accepted structures for the free and cTnI-
(33-80)-bound forms of cTnC(81-161) are given in Figure
4. The region 81 through 93 is highly disordered as evidenced
by a lack of NOEs, by the amide proton exchange rates, and
also by the magnitude of 15N{1H} heteronuclear NOEs for
cTnC(81-161) in the bound complex (Figure 5). Both the
free and cTnI(33-80)-bound forms of cTnC(81-161) exhibit
well-defined EF-hand folded domains. Structural statistics
for both free and cTnI(33-80)-bound cTnC(81-161) are
Table 2: Summary of Secondary Structural Elements for
CTnC(81-161) Free and Complexed to CTnI(33-80)
cTnC(81-161)secondary
structure free cTnI(33-80)-bound
R-helix
E 93-103 93-103
F 114-123 114-123
G 130-139 130-139
H 150-158 150-158
â-sheet 111-113 111-113
147-149 147-149
FIGURE 4: Final set of 20 accepted structures for cTnI(33-80)-bound (A) and free (B) forms of cTnC(81-161). Residues 81 through 94
are disordered in both the free and bound forms of cTnC(81-161). The backbone atoms (N, CR, C′) of residues 93 through 161 are shown
in both the free and bound forms.
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given in Table 3. The global folds for both the free and bound
forms of cTnC(81-161) are defined by 119 and 120,
respectively, long-range NOEs. The superposition of back-
bone atoms (N, CR, C′) for the 20 best free and bound
structures of cTnC(81-161) yields rms deviations of 1.0 and
0.72 Å, respectively (Table 3). Ramachandran plots, calcu-
lated with the program Procheck-NMR V.3.4.4, for the free
and bound forms of cTnC(81-161) showed that 78 and 87%,
respectively, of the amino acid residues fall in the most
favorable ª, regions including all residues in loop regions.
Our structure for the free C-terminal domain of cTnC is very
similar to that previously reported by Sykes’ group (5).
Conformational differences were observed between the more
biologically relevant cTnI-bound form of cTnC(81-161) and
the free protein (Figure 6). The rms deviation between CR
atoms for the average free and bound cTnC(81-161)
structures was 1.8 Å. Conformational differences within the
free and bound structures can be observed by comparison
of interhelical angles (Table 4). The binding of cTnI(33-
80) results mainly in an opening of the structure. In the free
protein, NOEs are observed from the aromatic group of
Phe104 to the methyl of Ala123. However, in bound cTnC-
(81-161), these NOEs are absent since the ends of helices
E and F have moved away from each other (Figure 6). The
side chain of Phe104 is rotated in bound cTnC(81-161),
explaining the absence of NOEs with Ala123 that were
observed in the free protein. Interactions between the
aromatic ring of Phe104 and residues located at the beginning
of the F helix are essential for holding the F helix in close
proximity to helix E. Movement of helix H results in a
translation of the aromatic ring of Phe156 away from residues
FIGURE 5: Relaxation parameters for free and cTnI(33-80)-bound
cTnC(81-161). 15N transverse relaxation rates for free (A) and
cTnI(33-80)-bound cTnC(81-161) (B). {1H}-15N steady-state
NOE values for free (C) and cTnI(33-80)-bound cTnC(81-161)
(D). Data were acquired at 600 MHz as described under Materials
and Methods. The overall secondary structure of cTnC(81-161)
bound to cTnI(33-80) is provided at the bottom.
FIGURE 6: Ribbon diagram showing the best fit superposition of
mean structures for free and cTnI(33-80)-bound cTnC(81-161).
The C-terminal domain of cTnC contains four R-helices (E, F, G,
and H) and a short antiparallel â-sheet located between calcium
binding sites III and IV. Free cTnC(81-161) is represented in green,
and cTnI(33-80)-bound cTnC(81-161) is represented in red. Side
chains of Phe104, Ala123, and Phe156 are shown to illustrate
differences between the free and bound forms.
Table 3: Statistics for Ca2+-Saturated CTnC(81-161) Free and
CTnI(33-80)-Bound Structures
number
free bound
distance restraints
total NOE 678 788
intraresidue NOE 168 227
sequential NOE 242 271
medium-range NOE 149 170
long-range NOE 119 120
hydrogen bond distance 4 4
dihedral 60 92
total restraints 742 884
X-PLOR energies (kcal/mol) 〈SA〉a 〈SA〉
Etotal 81 85
Ebond 1.1 1.3
Eangle 67 69
Eimproper 11 11
Evdw 1.3 2.6
ENOE 0.9 1.1
Ecdih 0.05 0.2
rmsd values 〈SA〉 〈SA〉
backboneb 1.0 0.72
helices, â-sheets, and Ca2+ loopsc 0.8 0.60
violations
distance restraints 0 0
dihedral restraints 0 0
a 〈SA〉 is the ensemble of 20 final X-PLOR structures. Interresidue
restraints can be defined as NOEs between side-chain protons that are
more than four bonds apart. b Residues 94-158. c Residues 94-124
and 130-158.
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at the beginning of helix F (Figure 6). These movements
promote a small “opening” in the structure as observed by
the slight decrease in the E/F and G/H interhelical angles
(Table 4). The consequence of this is that the C-terminal
domain is less compact than in the free structure. This
opening is also responsible for movement of the loop,
residues 124 through 129, connecting helices F and G (Figure
6). The hydroxyl proton of Thr124 could be assigned as a
broad resonance at 5.45 ppm in the CN-NOESY-HSQC
spectrum in the complex. Nuclear Overhauser effects were
observed from the hydroxyl proton of Thr124 to its own
amide and to the amide proton of Glu126 only in the bound
protein. Formation of a hydrogen bond between the Hç1 of
Thr124 and the backbone carbonyl of Leu121 could help
stabilize the loop region in the bound structure. Together,
the results of these movements provide the binding site for
the N-terminal domain of cTnI.
The binding site for cTnI(33-80) was determined by
mapping amide proton and nitrogen chemical shift changes
onto the C-terminal cTnC structure. Figure 7A shows a
molecular surface for the bound form of Ca2+-saturated
cTnC(81-161) with residues whose amide proton or nitrogen
chemical shifts are significantly perturbed upon complex
formation. For comparison, a similar view is shown for the
free protein (Figure 7B). Chemical shift differences were
measured from the 1H-15N HSQC spectra of 15N-labeled
cTnC(81-161) both free and bound to cTnI(33-80) (Figure
2). Resonances for both free and bound cTnC(81-161) were
independently assigned since a titration with free cTnI(33-
80) could not be readily performed due to its insolubility.
The largest chemical shift changes were observed in the loop
region connecting helices F and G as well as the beginning
of helix G and the end of helix H. The largest rms deviations
for individual amino acid residues between the free and
bound structures were also found for residues in the loop
region between helices F and G and residues in the
C-terminal portion of helix H. Many of the amino acid
residues in cTnC, whose chemical shifts were perturbed upon
cTnI(33-80) binding, are conserved in sTnC and found to
interact with sTnI in the X- ray structure (6). The backbone
rms deviation between residues 94-158 in cTnC bound to
cTnI(33-80) and residues 92-156 of sTnC in the crystal
structure was 1.5 Å. This general agreement between the
solution structure for cTnC(81-161)/cTnI(33-80) and the
crystal structure for sTnC/cTnI(1-47) suggests a common
binding motif for the Ca2+/Mg2+-dependent interaction site
in the TnIC complex.
DISCUSSION
We have compared structures of the C-terminal domain
of cTnC both free in solution and bound to the N-terminal
domain of cTnI. The structure of free cTnC(81-161) is
nearly identical to that previously determined for the C-
terminal domain of cTnC (5), as well as for the crystal
structure of the C-terminal domain of sTnC (47). However,
in the complex, an opening of the hydrophobic pocket occurs
as a consequence of movement in helices E, F, and H to
accommodate binding of the N-terminal domain of cTnI.
Movement of the loop, residues 124-129, connecting helices
F and G is also important for formation of the cTnI binding
pocket (Figure 6). The consequence of these movements is
that the C-terminal domain is less compact than in the free
structure providing the binding site for the N-terminal domain
of cTnI. This conformational change results in a rms
deviation for backbone atoms between free and cTnI(33-
80)-bound cTnC(81-161) of 1.9 Å (residues 94-158).
Binding of sTnI(1-47) to sTnC was also found to not
greatly perturb the conformation of the C-terminal domain
of sTnC (6). In skeletal TnC, the rms deviation for CR atoms
between the free and cTnI(1-47)-bound C-terminal domains
of sTnC was only 1.1 Å (6). Comparison of the CR atoms
for bound skeletal and cardiac structures gives a rms
deviation of 1.5 Å. Essential agreement between the cardiac
and skeletal structures is further supported by the residues
showing the largest rms deviations between the free and
bound structures. The CR residues showing the largest
deviation between the average free and bound forms for
cTnC(81-161) are Glu95 and -135, and the region compris-
ing residues 122 through 128 (Figure 6). This region includes
the end of helix F, the loop region between helices F and G,
and the end of helix H. The largest CR residue rms deviations
between the C-terminal free and bound forms of sTnC also
occur in the loop region between helices F and G (6).
{1H}-15N heteronuclear NOEs for cTnC(81-161) show
a decrease in mobility for the loop region between helices F
and G upon binding cTnI(33-80) (Figure 5C,D). This result
is consistent with the observed decrease in available con-
formational space for backbone atoms in this region upon
binding cTnI(33-80) (Figure 4). The magnitude of 15N
transverse relaxation rates for cTnC(81-161) is consistent
with the free and cTnI(33-80)-bound proteins having
different overall tumbling times (Figure 5A,B). However, a
decrease in 15N transverse relaxation rates was not observed
in the loop region between helices F and G in free cTnC-
(81-161). This is likely due to the fact that individual local
motions in this region are not significantly faster than the
overall tumbling of the molecule. However, this decrease in
15N transverse relaxation rates for the loop region between
helices F and G in free full-length [15N,2H]cTnC has been
observed (48). Additional relaxation studies of side chains
are needed to develop a more comprehensive picture of the
mobility occurring at the interface between these two
proteins. Restriction of backbone mobility upon complex
formation is not unusual (49-51). Thus, some of the apparent
differences observed in the loop region between free and
bound cTnC(81-161) may result from differences in the
flexibility in the loop regions. Studies of side-chain dynamics
for cTnC bound to N-terminal cTnI peptides are in progress.
These results are expected to more completely characterize
motional disorder observed at the interface, especially in
cTnI.
In cTnC, hydrophobic residues whose chemical shifts are
significantly perturbed upon complex formation include
Leu97, Leu100, Met120, Leu121, Ile128, Phe156, Met157,
Table 4: Interhelical Angles in Ca2+-Saturated CTnC(81-161) Free
and CTnI(33-80)-Bound
cTnC(81-161) interhelical angles (deg)a
helix pair free cTnI(33-80)-bound sTnC/sTnI(1-47) X-rayb
E/F 112 ( 7 94 ( 8 99
G/H 116 ( 7 89 ( 8 109
a Calculated using a program from Mitsuhiko Ikura from the
University of Toronto. Calculated using the 20 NMR-derived solution
structures for both the free and cTnI(33-80)-bound forms of cTnC(81-
161). The start and end points for the helices are as follows: E, 93-
103; F, 114-123; G, 130-139; H, 150-158. b Calculated from the
sTnC/sTnI(1-47) crystal structure by Vassylyev et al. (6).
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and Val160. These residues correspond to hydrophobic
residues Leu95, Cys98, Ile118, Phe119, Val126, Met154,
Met155, and Va1158 in sTnC which make contact with sTnI-
(1-47) in the crystal structure (6). In addition, polar
interactions in the skeletal complex include Lys90, Glu97,
Arg100, Arg104, Glu124, and His125 (6). These interactions
correspond to cTnC residues Lys92, Asp99, Arg102, Lys106,
Glu126, and Thr127 that also undergo significant amide
proton and nitrogen chemical shifts upon complex formation
in the cardiac complex. In the crystal structure of sTnC/sTnI-
(1-47), sTnI formed a 31 residue helix which was found to
interact with both hydrophobic and amphiphilic amino acids
in the C-terminal end of sTnC. However, the C-terminal end
of sTnI(1-47) was found to be disordered in the crystal
structure. Interestingly, solution studies on [15N,13C]-labeled
cTnI(33-80) bound to cTnC revealed a high degree of
disorder at the protein-protein interface (Abbott, unpublished
results). Disorder in the side chains of several resonances in
the C-terminal domain of cTnC was also observed, along
with conformational heterogeneity at the beginning of the F
helix and at the end of the H helix in free cTnC(81-161).
Our results provide a direct comparison of solution
structures for the C-terminal domain of cTnC free and bound
to the conserved N-terminal domain of cTnI, corresponding
to residues 33 through 80. The tertiary structures of both
the free and bound proteins are similar with the largest
deviations occurring in the loop region between helices F
and G. Comparison of interhelical angles shows that the
bound form of cTnC(81-161) is more “open” than the free
protein, providing a larger surface area for interaction with
cTnI. Our data also show that unwinding of the linker region
in TnC is not essential for TnC/TnI complex formation.
Unwinding of the linker region or central helix in sTnC was
observed in the 2Ca2+sTnC complex with sTnI(1-47) (6).
This permitted interaction of both the N- and C-terminal
domains of sTnC with sTnI(1-47). In the crystal structure,
both regulatory sites in the N-terminal domain are empty.
We have assigned the full-length Ca2+-saturated cTnC bound
to cTnI(1-80, S23D, S24D), a stable mimetic for the
phosphorylated form of cTnI, and see no significant backbone
amide proton or nitrogen chemical shift changes in the
N-terminal domain of cTnC upon complex formation (Finley,
unpublished). These studies, along with dynamic studies on
Ca2+-saturated cTnC free and bound to cTnI(1-80, S23D,
S24D), suggest that in the presence of saturating calcium
the N-terminal domain of cTnC has little or no interaction
with the phosphorylated form of the N-terminal domain of
cTnI. Thus, important differences may exist in the nature of
the molecular interactions between the N -terminal domains
of skeletal and cardiac TnC and the N-terminal domain of
TnI. However, the observation that TnC structures for both
cardiac and skeletal C-terminal domains are similar indicates
a common motif for the Ca2+/Mg2+-dependent TnC and TnI
interaction site. The C-terminal domain contains two high-
affinity binding sites that under physiological conditions can
be occupied by either Ca2+ or Mg2+. In both the cardiac and
skeletal troponin systems, interaction between the C-terminus
of TnC and the N-terminus of TnI is thought to be
responsible for the tight association of the complex. In the
cardiac complex, it is clear that the N-terminus of TnI plays
an additional role aside from maintaining tight association
of the two proteins. The cardiac-specific amino terminus
contains two protein kinase A sites that are known to
modulate the Ca2+ sensitivity of the myofibrils upon phos-
phorylation. Phosphorylation at these sites has been dem-
onstrated to modulate the calcium affinity at the regulatory
site by altering the interactions between cTnI and cTnC (52).
Cardiac TnI also contains two protein kinase C sites at Ser43
and Ser45 that are functionally significant, and it appears
likely that phosphorylation of these sites may affect the
cTnI-cTnC interface (53).
These studies provide the first direct comparison of the
free and cTnI bound C-terminal domain in cTnC. Using the
bound structure of cTnC(81-161), we have been able to map
FIGURE 7: GRASP (54)-calculated molecular surfaces for Ca2+-saturated cTnC(81-161) bound to cTnI(33-80) and free in solution. (A)
Ca2+-saturated cTnC(81-161) bound to cTnI(33-80). (B) Ca2+-saturated cTnC(81-161). Regions of hydrophobic, charged, and polar
residues are colored yellow, red, and blue, respectively. Residues having the absolute value of the amide proton and/or amide nitrogen
chemical shift difference between the free and cTnI(33-80)-bound forms greater than the average chemical shift difference plus one standard
deviation are labeled. Average chemical shift differences plus one standard deviation in 1H and 15N were 0.21 and 1.2 ppm, respectively.
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the binding site of the N-terminal domain of cTnI. Com-
parison of the bound cardiac structure with the crystal
structure of the bound skeletal isoform shows that many of
the binding interactions are conserved. The role and impor-
tance of particular amino acids can now be explored using
site-directed mutagenesis. Structural studies on cTnC/cTnI-
(1-80) and cTnC/cTnI(1-80, S23D, S24D), mimicking the
PKA-phosphorylated N-terminus of cTnI, are now in progress.
These studies will help elucidate the role of dynamics in
transmission and modulation of the calcium signal.
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